FENLAND GROUP PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: D81611 | MARCH, PE15 0GN
Showing results 401-450 of 680
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder 1.6 kcal/ml milkshake (0913011) | 51 | 7,418 | £577 | -31.6% ▼ |
| 51 | 1,050 | £3.4K | +214.7% ▲ | |
| Haloperidol | 50 | 787 | £2.7K | +5.0% ▲ |
| Dosulepin hydrochloride | 50 | 2,531 | £543 | -11.7% ▼ |
| Denosumab | 50 | 50 | £8.2K | +83.7% ▲ |
| Hydrocortisone acetate | 49 | 1,530 | £279 | -25.8% ▼ |
| 49 | 21.5K | £160 | -46.3% ▼ | |
| Brivaracetam | 48 | 2,086 | £4.6K | +41.1% ▲ |
| Exemestane | 48 | 773 | £143 | +47.7% ▲ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 48 | 151.3K | £2.6K | +25.8% ▲ |
| Tube feed 1.5 kcal/ml with fibre (0914011) | 48 | 1.2M | £21.4K | +315.3% ▲ |
| Formoterol/glycopyrronium/budesonide | 47 | 47 | £1.9K | -22.0% ▼ |
| Sennosides | 46 | 15.7K | £302 | +49.0% ▲ |
| Domperidone | 46 | 3,632 | £119 | +29.0% ▲ |
| Olopatadine | 46 | 230 | £221 | +4.9% ▲ |
| Brinzolamide/brimonidine | 46 | 265 | £435 | +34.1% ▲ |
| 46 | 1,980 | £9.7K | +296.1% ▲ | |
| Clomipramine hydrochloride | 45 | 2,996 | £627 | +6.7% ▲ |
| Aclidinium bromide | 44 | 54 | £1.6K | +65.8% ▲ |
| Diamorphine hydrochloride (Systemic) | 44 | 6,328 | £18.6K | +560.4% ▲ |
| Prucalopride | 43 | 1,204 | £595 | +10.4% ▲ |
| Lacidipine | 43 | 1,184 | £113 | -64.0% ▼ |
| Fluticasone furoate/vilanterol | 43 | 43 | £1.0K | -72.2% ▼ |
| Rifaximin | 43 | 2,415 | £9.5K | +60.2% ▲ |
| Tacrolimus | 43 | 1,800 | £1.3K | -20.3% ▼ |
| Ivermectin | 43 | 2,175 | £1.2K | +102.2% ▲ |
| Lidocaine | 42 | 1,470 | £381 | +265.4% ▲ |
| Losartan potassium with diuretic | 41 | 1,148 | £223 | +59.9% ▲ |
| Dalteparin sodium | 41 | 991 | £3.4K | +148.2% ▲ |
| Phenytoin sodium | 41 | 1,936 | £555 | -49.2% ▼ |
| Brinzolamide and timolol | 41 | 295 | £425 | +8.5% ▲ |
| Carmellose sodium | 41 | 2,040 | £307 | -36.7% ▼ |
| Mometasone furoate/olopatadine hydrochloride | 40 | 41 | £507 | +268.2% ▲ |
| Buspirone hydrochloride | 39 | 1,212 | £151 | -22.6% ▼ |
| Vortioxetine | 39 | 1,092 | £971 | -43.8% ▼ |
| Codeine phosphate | 38 | 30.7K | £1.2K | +164.8% ▲ |
| 38 | 81 | £2.3K | +318.8% ▲ | |
| 38 | 440 | £788 | +15.7% ▲ | |
| Cinnarizine | 37 | 4,223 | £212 | -20.9% ▼ |
| 37 | 42 | £97 | +14.2% ▲ | |
| 37 | 370 | £42 | -1.6% vs avg | |
| Naloxegol | 36 | 150 | £245 | +161.0% ▲ |
| Phenobarbital | 36 | 2,660 | £171 | +17.1% ▲ |
| Menthol | 36 | 13.2K | £455 | +27.8% ▲ |
| 36 | 3,451 | £143 | -57.7% ▼ | |
| Glycopyrronium/formoterol | 35 | 35 | £1.0K | +38.4% ▲ |
| Sevelamer | 35 | 3,015 | £449 | +59.7% ▲ |
| Atropine sulfate | 35 | 760 | £3.6K | +174.7% ▲ |
| 35 | 4,150 | £1.5K | +138.2% ▲ | |
| 35 | 92 | £1.0K | +12.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.